News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

Older adults who added hazelnuts to their diet for a few months significantly improved their levels of two key micronutrients.

A genetic switch that causes latent HIV inside cells to begin to replicate can be manipulated to completely eradicate the virus from the human body.

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.

A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment.

NIBIB-funded researchers recently validated a rapid STD test that delivered accurate results in about 30 minutes for chlamydia, allowing patients to receive treatment immediately, thereby stemming the further spread of disease.

Researchers from Aarhus University have contributed to creating new knowledge about resistance to yellow rust, which is a serious fungal disease in wheat. The results can have global importance.

Emerging contaminants in our water system, including pharmaceuticals and personal care products, hormones, perfluorinated alkyls and volatile organics, may pose a threat to both the environment and human health.

Researchers from CIRAD and INRA recently showed that inactivating a gene, RECQ4, leads to a three-fold increase in recombination in crops such as rice, pea and tomato.